Thirty-First Board Meeting

Minister Benedict Xaba from the Eastern and Southern Africa constituency is designated as Rapporteur for the Thirty-First Board Meeting.

<p>The agenda for the Thirty-First Board Meeting (GF/B31/01) is approved.</p>

<p>The report of the Thirtieth Board Meeting (GF/B31/02) is approved.</p>

<ol> <li>Based on the recommendation of the Finance and Operational PerformanceCommittee (the “FOPC”), the Board approves the 2014 operating expenses budgetin the amount of USD 298.8 million, as set forth in GF/B31/03 Part A (the “2014Operating Expenses Budget”), which includes USD 20.5 million for the Office ofthe Inspector General’s 2014 operating expenses.</li> <li>As previously decided by the Board (GF/B22/DP18), the Secretariat willmanage the 2014 Operating Expenses Budget’s exposure to foreign-exchange ratevolatility and include in its periodic reporting to the FOPC on budget mattersany measures taken to minimize such exposure.</li> </ol>

<ol> <li>Based on the recommendation of the Finance andOperational Performance Committee, the Board approves the amended and restatedComprehensive Funding Policy, as set forth in GF/B31/04 – Annex 1 (the “Amendedand Restated CFP”). </li> <li>The Amended and Restated CFP supersedes all priorversions of the Comprehensive Funding Policy, and any related decisionspreviously adopted by the Board or its Committees that are inconsistent withthe Amended and Restated CFP. </li> </ol>

<ol> <li>The Board notes that a portion of sources of funds may be excluded from the allocation to Country Bands for future utilization towards initiatives that are not adequately accommodated through the allocation of resources to Country Bands (Annex 1 to GF/B27/DP7) (the “Special Initiatives”). </li> <li>Based on the recommendation of the Strategy, Investment and Impact Committee (the “SIIC”), the Board decides that up to USD 100 million will be available over the 2014 – 2016 allocation period for the following Special Initiatives, as described in GF/B31/08A – Revision 1, in the amounts listed below: <ol type="a"> <li>USD 30 million for the Humanitarian Emergency Fund;</li> <li>USD 17 million for Country Data Systems; </li> <li>USD 29 million for Technical Assistance for Strong Concept Notes and PR Grant-making Capacity Building; </li> <li>USD 15 million for Technical Assistance on Community, Rights and Gender; and</li> <li>USD 9 million for Enhancing Value for Money and Financial Sustainability of Global Fund Supported Programs.</li> </ol> </li> <li>The funds available for Special Initiatives may be reallocated by the Secretariat among the Special Initiatives set forth under paragraph 2 above, upon the SIIC’s approval, in consultation with the Finance and Operational Performance Committee (the “FOPC”), of an updated budget and plan to implement such initiatives.</li> <li>The Secretariat shall recover investments towards Special Initiatives from funding provided through grant programs whenever possible.</li> <li>With respect to the use of funds available for the Special Initiatives, the Board requests the Secretariat to report to the FOPC on the financial implications and to the SIIC on the operational and strategic implications. </li> </ol>

<ol> <li>The Board notes that a portion of sources of funds may be excluded from the allocation to Country Bands for future utilization towards investments that are not adequately accommodated through the allocation of resources to Country Bands (Annex 1 to GF/B27/DP7). </li> <li>Based on the recommendation of the Strategy, Investment and Impact Committee, as set forth in GF/B31/08B, the Board: <ol type="a"> <li>Decides that USD 200 million will be available for new Regional Programs over the 2014 – 2016 allocation period;</li> <li>Recognizes that Regional Programs will be presented to the Board for funding approval throughout the 2014 – 2016 allocation period; and</li> <li>Acknowledges funding applications that are submitted by a group of small island economies or other small countries that typically would not apply as individual countries due to inherent administrative inefficiencies (the “Multi-Country Applications”) will be funded from amounts allocated to the individual disease components participating in each Multi-Country Application. </li> </ol> </li> </ol>

<ol> <li>The Board acknowledges: <ol type="a"> <li>The Finance and Operational Performance Committee’s recommendation on the amount of announced replenishment results for the 2014 – 2016 Replenishment Period, net of certain adjustments and qualifying deductions, that will be allocated to Country Bands at the start of the Allocation Period (the “Initial Allocation”), as set forth in GF/B31/06, in accordance with the Comprehensive Funding Policy, as amended and restated under decision point GF/B31/DP05; and</li> <li>The Board’s approval of the Strategy, Investment and Impact Committee’s recommendation to apportion USD 100 million to finance Special Initiatives and USD 200 million to finance Regional Programs over the 2014 – 2016 period (GF/B31/DP06 and GF/B31/DP07 respectively).</li> </ol> </li> <li>Accordingly, the Board decides the Initial Allocation for the 2014 – 2016 Replenishment Period is USD 10.22 billion.</li> </ol>

<ol> <li>The Board notes its prior decision to approve the Amended and Restated Comprehensive Funding Policy (GF/B31/DP05) (the “CFP”) as a standard financial management framework, and acknowledges unique measures are required to facilitate the 2014 allocation of resources to Country Bands, the first under the allocation-based funding model, to manage the transition from the rounds-based system.</li> <li>Accordingly, based on the joint recommendation of the Finance and Operational Performance Committee (the “FOPC”) and the Strategy, Investment and Impact Committee (the “SIIC”), the Board adopts the following transition framework: <ol type="a"> <li>The total amount that will be allocated to Country Bands (the “Total Allocation”) using the allocation methodology will be comprised of the following amounts: <ol type="i"> <li>The Initial Allocation, in the amount of USD 10.22 billion, as approved under decision point GF/B31/DP08, which will determine the amount of incentive funding; and</li> <li>The amount of Sources of Funds, as defined in the CFP, originating from the Third Replenishment Period (2011 – 2013), or earlier, which have not been disbursed as at 31 December 2013 (the “Existing Funds”), in the amount of USD 5.55 billion, as recommended by the FOPC.</li> </ol> </li> <li>While each grant applicant’s portion of the Total Allocation must be requested by the applicant and approved by the Board prior to 31 December 2016, it may be utilized beyond such date in accordance with the terms of the relevant grant agreement;</li> <li>The Total Allocation will address the remaining pipeline of grant funding due to Board-approved proposals or other Board decisions originating from the Third Replenishment Period, or earlier, as at 31 December 2013, (the “Existing Grants Pipeline”) while taking a comprehensive approach such that performance and strategic impact are reflected in the investment of the entirety of funds;</li> <li>While each disease component’s portion of the Total Allocation will typically cover a period of four years starting from 1 January 2014, the Secretariat, working together with countries and/or regions, has the operational flexibility to structure longer or shorter grant implementation periods while applying the principles of the allocation model (GF/B28/DP4) to guide funding levels towards the amounts derived from the allocation formula;</li> <li>Accordingly, a 25-percent target minimum reduction compared to the most recent available four-year disbursement levels (the “Graduated Reduction”) will be applied across the portfolio of disease components that have funding levels above their notional shares under the allocation methodology; and</li> <li>If a disease component’s Existing Grants Pipeline exceeds the amount that would result from applying the Graduated Reduction described in paragraph 2.e. above, then instead of applying the Graduated Reduction, the disease component’s Existing Grants Pipeline will serve as a basis to determine its total allocation starting from 1 January 2014.</li> </ol> </li> <li>The Board notes the transition framework established under this decision represents measures tailored to address the unique circumstances and challenges of transitioning from the rounds-based system to the allocation-based funding model and shall not apply to subsequent allocations and Replenishment Periods.</li> </ol>

<ol> <li>Based on the recommendations of the Strategy, Investment and Impact Committee (the “SIIC”), the Board approves the composition of Country Bands for the 2014 – 2016 allocation period, as defined and set forth in Annex 1 to GF/B31/09 – Revision 1.</li> <li>In accordance with its decision to approve the transition framework recommended by the Finance and Operational Performance Committee and the SIIC (GF/B31/DP09), the Board acknowledges USD 15.8 billion is available for allocation to Country Bands for the 2014 – 2016 allocation period, consisting of the following: <ol type="a"> <li> USD 14.8 billion for indicative funding; and</li> <li> USD 950 million for incentive funding.</li> </ol> </li> <li>The Board approves the following allocation of indicative funding for the 2014 – 2016 allocation period: <ol type="a"> <li> Country Band 1: USD 11,250 million;</li> <li> Country Band 2: USD 915 million;</li> <li> Country Band 3: USD 1,530 million; and</li> <li> Country Band 4: USD 1,105 million.</li> </ol> </li> <li>The Board also decides incentive funding, in the amount of USD 950 million, will be apportioned across and within Country Bands 1, 2 and 3 in accordance with the methodology approved by the SIIC under authority delegated by the Board (GF/SIIC09/DP2). </li> </ol>

<ol> <li>Based on the recommendation of the Audit and Ethics Committee, the Board approves the Policy for Disclosure of Reports Issued by the Inspector General, as revised and set forth in Annex 1 to GF/B31/12, which supersedes and replaces the disclosure policy adopted by the Board under GF/B20/DP23.</li> <li>Accordingly, the Board approves the following revision to Section 15 of the Charter of the Office of the Inspector General <a>[1]</a>(the “OIG Charter”) to align the OIG Charter with the revised Policy for Disclosure of Reports Issued by the Inspector General:</li> </ol> <blockquote> <p>“15. Reporting: Final reports of Office of the Inspector General regarding its <span style="text-decoration: line-through;">external</span> assurance and investigations work will be posted on the Global Fund’s public internet site in accordance with the Board-approved ‘Policy for Disclosure of Reports Issued by the Inspector General’<span style="text-decoration: line-through;">. Internal assurance findings will be promptly reported to the Executive Director and the AEC for internal action.</span>”</p> </blockquote>

<ol> <li>The Board decides: <ol type="a"> <li>The Secretariat is authorized to extend a grant’s implementation period by a maximum of 12 months beyond the end date set forth in the relevant grant agreement: <ol type="i"> <li>When the extension does not require funding in addition to the amounts approved by the Board for such implementation period ; or</li> <li>When any portion of the extension requires funding in addition to the amounts approved by the Board for such implementation period, provided the period of additional funding does not exceed six months and the amount of additional funding does not exceed USD 10 million.</li> </ol> </li> <li>Any other circumstances warranting an extension will be recommended by the Secretariat to the Board for approval. </li> <li>The Secretariat will develop a framework for exercising the authority delegated under this decision, and report to the Board the extensions approved by the Secretariat under such authority through the monthly Grant Approvals Committee Report on funding recommendations.</li> <li>The Secretariat will review the implementation of this decision and present any recommended modifications to the Strategy, Investment and Impact Committee for approval.</li> </ol> </li> <li>The Board also decides that as of the date of this decision, the extension framework adoptedunder this decision supersedes all prior policies and decisions concerningextensions whether in whole or with respect to relevant parts, including thefollowing Board Decision Points:</li> <li>B24/EDP/5: Procedure forRolling Continuation Channel Mid-Term Performance Reviews and Extensions;</li> <li>GF/B20/DP31: ArchitectureReview – Transition Provisions;</li> <li>GF/B16/DP7, GF/B14/DP27 and GF/B13/DP2: Phase 2Decision-Making Policies and Procedures; and</li> <li>GF/B26/DP5: Delegation of Authority to Secretariat forGrant Operations. </li> </ol>

<ol> <li>The Board acknowledges the recommendations set forth in GF/B31/10 outlining the membership appointment recommendations for the Board’s Audit and Ethics Committee (the “AEC”).</li> <li>Accordingly, the Board approves the appointment of the following individuals to the AEC for a term that will expire on 9 March 2016, or until the appointment of their respective successors: <ol type="a"> <li>Graham Jocelyne as independent Chair of the AEC;</li> <li>Mohammed Abdellatif as independent member of the AEC;</li> <li>Gabor Amon as independent member of the AEC;</li> <li>Wendy Harrison as independent member of the AEC; and</li> <li>Christopher Kassami as a constituency-nominated member from the Eastern and Southern Africa Constituency.</li> </ol> </li> </ol>

<ol> <li>The Board acknowledges the nominations for membership of the Board’s Strategy, Investment and Impact Committee (the “SIIC”), as set forth in GF/B31/10”.</li> <li>Accordingly, the Board approves the appointment of the following individuals to serve as voting members of the SIIC, representing the Board constituencies listed by their name, for a term that will expire on 9 March 2016, or until the appointment of their respective successors: <ol type="a"> <li>Aida Kurtovic, Eastern Europe and Central Asia;</li> <li>Vinand Nantulya, Eastern and Southern Africa;</li> <li>Abdalla Osman, Eastern Mediterranean Region;</li> <li>Mirta Roses, Latin America and the Caribbean;</li> <li>Asia Russell, Developed Country NGO;</li> <li>Helga Fogstad, Point 7;</li> <li>Jason Lane, UK-Australia;</li> <li>Julia Martin, USA;</li> <li>Philippe Meunier, France; and</li> <li>Jan Paehler, European Commission.</li> </ol> </li> <li>Noting that the Chair of the Technical Review Panel and the Technical Evaluation Reference Group serve as non-voting members of the SIIC, the Board appoints the following individuals to serve as additional non-voting members of the SIIC, representing the Board constituencies listed by their name, for a term that will expire on 9 March 2016, or until the appointment of their respective successors: <ol type="a"> <li>Lucica Ditiu, Partners; and</li> <li>Mbulawa Mugabe, UNAIDS.</li> </ol> </li> <li>The Board decides to launch a new call for nominations for the Finance and Operational Performance Committee (the “FOPC”) with a due date for nominations by 26 March 2014. The Chair and Vice-Chair of the Board will present its recommendation of candidates to the Board for approval by 15 April 2014.</li> <li>The Board notes that qualified candidates that have already been nominated, but not appointed, for a Committee role will remain in consideration for FOPC membership.</li> <li>The Board urges constituencies to nominate additional candidates that clearly demonstrate the competencies and skills that are required to perform the responsibilities of FOPC members. </li> </ol>

<p>The Board:</p> <ol> <li>Approves extension of the relevantimplementation periods and, where applicable, the additional funding requested forthe grants listed in Table 1.</li> </ol> <p>See attached table detailing total recommended funding amount of US$ 35,730,528 for the following Ukraine grants: UKR-011-G08-H, UKR-011-G09-H and UKR-011-G10-H.</p>

<p>The Board authorizes the issuance of, and therefore approves, the Global Fund’s 2013 Annual Financial Report, which includes the 2013 Consolidated Financial Statements that have been audited by Ernst &amp;amp; Young Ltd, as set forth in GF/B31/ER02 Annex 1.</p>

<p>The Board authorizes the issuance of, and therefore approves, the Global Fund’s 2013 Statutory Financial Statements, which have been audited by Ernst &amp; Young Ltd, as set forth in GF/B31/ER02 Annex 2. </p>

<ol> <li>The Board acknowledges the nominations for membership of the Board’s Finance and Operational Performance Committee (the “FOPC”), as set forth in GF/B31/ER03 Revision 1”.</li> <li>Accordingly, the Board approves the appointment of the following individuals to serve as voting members of the FOPC, representing the Board constituencies listed by their name, for a term that will expire on 1 May 2016 or until the appointment of their respective successors: <ul> <li>Hristijan Jankuloski, Developing Country NGO;</li> <li>Ren Minghui, Western Pacific Region;</li> <li>Nilaya Mitash, South East Asia;</li> <li>Rachel Ong, Communities;</li> <li>Safiatou Thiam, West and Central Africa;</li> <li>Kieran Daly, Private Foundations;</li> <li>Arun Thangaraj, Canada and Switzerland;</li> <li>Reinhard Tittel-Gronefeld, Germany;</li> <li>Nazzereno Todini, Private Sector; and</li> <li>Takeshi Osuga, Japan.</li> </ul> </li> <li>The Board appoints the following individuals to serve as non-voting members of the FOPC, representing the Board constituencies listed by their name, for a term that will expire on 1 May 2016, or until the appointment of their respective successors: <ul> <li>Alexandru Cebotari, World Bank; and</li> <li>Martins Pavelsons, Partners.</li> </ul> </li> </ol>

<p>The Board:</p> <ol> <li>Approves additional funding for the next implementation period for the grants listed in Table 1 in the amounts indicated for each grant, based on the understanding that the amounts approved are upper ceilings rather than final funding amounts for that period and that on-going implementation arrangements for each grant shall be pursued by the Secretariat consistent with the principles of the recommendations set forth in the related documentation submitted to the Board and in accordance with Global Fund policies. Approval is also subject to the availability of funding and to the provision that funding for renewals of existing grants shall be committed in annual tranches (GF/B25/DP16, paragraph 7 of Annex 1).</li> <li>Reaffirms that the maximum funding amount available for the next implementation period of each grant shall be the sum of the amount set out in Table 1 below for each listed grant and the amount of any funds approved for the prior implementation period which have not been utilized during that period, either as undisbursed funds or cash balances held by recipients under the grant.</li> </ol> <p>See attached table detailing total recommended funding amount of US$ US$ 309,646,766 for the following grants: ETH-T-FMOH for Ethiopia, KEN-H-KRC and KEN-H-MOF for Kenya, MOR-011-G04-H and MOR-011-G05-T for Morocco, UGD-T-MoFPED for Uganda.</p> <p>NOTES:</p> <ol type="a"> <li>Discrepancies between the CCM Request figures and the Program Scorecard result from the clarifications process with the CCM after the Request for Renewal was submitted and/or from corrections and adjustments made by the Global Fund Secretariat at the time of grant renewal review. Based on Board Decision GF/B26/DP7 on the Modification of Rules Governing Grant Renewals dated 11 May 2012, a modified ceiling of 90% of the TRP adjusted Phase 2 amount is applied to the Grant Renewals. This also takes into account discrepancies between the CCM Request figures and the Secretariat’s recommendation.</li> </ol>

<p>The Board:</p> <p>Approves, in accordance with its decision to launch the transition to the New Funding Model (GF/B28/DP5), incremental funding in the amount listed for the interim-applicant grant in Table 2 (the “Recommended Incremental Funding under the New Funding Model”), which will be in addition to the relevant grant’s total budget amounts that the Board has already approved for the implementation period. The Recommended Incremental Funding under the New Funding Model increases the upper-ceiling amount available for commitment rather than representing the final funding amount for the relevant implementation period, and is subject to the availability of funding and to the provision that the approved funding for the relevant grants shall be committed in annual tranches.</p> <p>See attached table detailing total recommended funding amount of EUR 731,918 for the following grant: MOL-H-PCIMU for Moldova.</p>

<p>TheBoard:</p> <p>Approvesextension of the relevant implementation period and, where applicable, theadditional funding requested for the grant listed in Table 3.</p> <p>See attached table detailing total recommended funding amount of US$ 12,973,121 for the following grant: SUD-011-G15-H for Sudan.</p>

<p>The Board approves the Report of the Thirty-First Board Meeting (GF/B31/19).</p>

<p>The Board:</p> <ol> <li>Approvesextension of the relevant implementation period and, where applicable, theadditional funding requested for the grant listed in Table 1.</li> </ol> <p>See attached table detailing total recommended funding amount of US$ 11,300,472 for the following grant: ZAR-911-G14-T for Democratic Republic of Congo (DRC).</p>

<p>The Board approves the Terms of Reference for the 2014 Ad-Hoc Working Group on Governance, as set forth in Annex 1 to GF/B31/ER06.</p>

<p>The Board approves the appointment of Ms. Jeya Wilson as an independent member of the Audit and Ethics Committee (the “AEC”) for a term that will expire on 9 March 2016, or until the appointment of her successor.</p>

<p>The Board:</p> <ol> <li>Approves additional funding for the next implementation period for the grant listed in Table 1, based on the understanding that the amount approved is upper ceilings rather than final funding amounts for that period and that on-going implementation arrangements for the grant listed shall be pursued by the Secretariat consistent with the principles of the recommendations set forth in the related documentation submitted to the Board and in accordance with Global Fund policies. Approval is also subject to the availability of the additional funding requested and to the provision that such additional funding if available shall be committed in annual tranches (GF/B25/DP16, paragraph 7 of Annex 1).</li> <li>Reaffirms that the maximum funding amount available for the next implementation period of the proposed grant shall be the sum of the amount set out in Table 1 below for the listed grant and the amount of any funds approved for the prior implementation period which have not been utilized during that period, either as undisbursed funds or cash balances held by recipients under the grant.</li> </ol> <p>Table 1: Secretariat’s Funding Recommendation</p> <p>See attached table detailing total recommended funding amount of EUR 971,313 for CAF-911-G09-T (Central African Republic).</p>

<p>The Board:</p> <ol> <li>Approves additional funding for the next implementation period for the grant listed in Table 2, based on the understanding that the amount approved is upper ceilings rather than final funding amount for that period and that on-going implementation arrangements for the grant shall be pursued by the Secretariat consistent with the principles of the recommendations set forth in the related documentation submitted to the Board and in accordance with Global Fund policies. Approval is also subject to the availability of the additional funding requested and to the provision that such additional funding if available shall be committed in annual tranches (GF/B25/DP16, paragraph 7 of Annex 1).</li> <li>Reaffirms that the maximum funding amount available for the next implementation period of the proposed grant shall be the sum of the amount set out in Table 2 below for the listed grant and the amount of any funds approved for the prior implementation period which have not been utilized during that period, either as undisbursed funds or cash balances held by recipients under the grant.</li> </ol> <p>Table 2: Secretariat’s Funding Recommendation for an Interim Applicant.</p> <p>See attached table detailing total recommended funding amount of EUR 21,336,770 for NGR-708-G07-M (Niger).</p>

<p>The Board:</p> <ol> <li>Approves extension of the relevant implementation periods and, where applicable, the additional funding requested for the relevant grant listed in Table 3.</li> </ol> <p>See attached table detailing total recommended funding amount of EUR 12,794,690 for BUR-H-SPCNLS (Burkina Faso) and US$ 1,277,361 for NEP-M-EDCD (Nepal).</p>

<p>The Board:</p> <ol> <li>Approves additional funding for the next implementation period for the grant listed in Table 1, based on the understanding that the amount approved is upper ceilings rather than final funding amounts for that period and that on-going implementation arrangements for the grant listed shall be pursued by the Secretariat consistent with the principles of the recommendations set forth in the related documentation submitted to the Board and in accordance with Global Fund policies. Approval is also subject to the availability of the additional funding requested and to the provision that such additional funding if available shall be committed in annual tranches (GF/B25/DP16, paragraph 7 of Annex 1).</li> <li>Reaffirms that the maximum funding amount available for the next implementation period of the proposed grant shall be the sum of the amount set out in Table 1 below for the listed grant and the amount of any funds approved for the prior implementation period which have not been utilized during that period, either as undisbursed funds or cash balances held by recipients under the grant.</li> </ol> <p>Table 1: Secretariat’s Funding Recommendation for a Grant Renewal</p> <p>See attached table detailing total recommended funding amount of EUR 981,882 for KOS-911-G05-T (Kosovo).</p>

<p>The Board authorizes the appointment of Ernst &amp; Young Ltd as the Global Fund’s external auditor for the 2014 fiscal year. </p>

The Board notes the Audit and Ethics Committee’s (the “AEC”) responsibility to oversee financial accounting and reporting matters and requests that, following a limited review by the Global Fund’s external auditor, the AEC reviews and authorizes the publication of interim condensed consolidated financial statements which have been prepared by the Secretariat.

<p>The Board:</p> <ol> <li>Approves extension of the relevant implementation periods and, where applicable, the additional funding requested for the relevant grant listed in Table 1.</li> </ol> <p>Table 1: Secretariat’s Recommendations on Grant Extensions</p> <p>See attached table detailing total recommended funding amount of US$ 3,561,367 for US$ 3,561,367 (Ethiopia) and US$ 3,561,367 for US$ 3,561,367 (Syrian Arab Republic).</p>

<p>The Board:</p><ol><li>Declines approval of additional funding for the next implementation period for the Round 10 Jordan TB grant (JOR-011-G04-T).</li></ol><p>Table 1: Secretariat’s Recommendation for Discontinuation of Funding for a Renewal </p><p><i>See attached table.</i></p>

<p>The Board:</p> <ol> <li>Approves extension of the relevant implementation periods and, where applicable, the additional funding requested for the relevant grant listed in Table 1.</li> </ol> <p>Table 1: Secretariat’s Recommendations on Grant Extensions</p> <p>See attached table detailing total recommended funding amount of US$ 69,353,613 for UGD-708-G07-H and US$ 1,200,000 for UGD-708-G13-H (Uganda).</p>

<ol> <li>The Board acknowledges the current political context and challenging implementation environment in Iraq due to ongoing conflicts. and</li> <li>Accordingly, the Board approves the following policy exceptions for processing IRQ-T-UNDP related transition funding application: <ol type="a"> <li>Maintaining the counterpart financing threshold at the level of 40%;</li> <li>Waiver of the “willingness to pay” requirement; and</li> <li>Waiver of the CCM eligibility requirements to access transition funding.</li> </ol> </li> </ol>

<p>The Board:</p> <ol> <li>Approves the establishment of a seven-member ad hoc nominations committee to assist the Board with its appointment of the next Inspector General (the “IG AHNC”) according to the Terms of Reference set out in Annex 1 of the Electronic Report to the Board that is numbered GF/B31/ER22.</li> <li>Appoints the following five individuals, based on nominations by the voting constituencies of the Board as well as the World Bank, to serve as members of the IG AHNC, each serving in his or her personal capacity: <ul> <li>Jan PAEHLER, who will also serve as Chair of the IG AHNC</li> <li>Pavel AKSENOV</li> <li>Galina MIKHLIN-OLIVER</li> <li>Navin RUGHOONUNUN</li> <li>Timothy ZIEMER</li> </ul> </li> <li>Delegates authority to the Board Chair, in consultation with the Board Vice Chair, and Chair and Vice Chair of the Audit and Ethics Committee, to appoint by 5 September 2014, the two remaining members of the IG AHNC that are not affiliated with a Board constituency, as stipulated in the Terms of Reference of the IG AHNC.</li> </ol>

<p>The Board:</p> <ol> <li>Approves the incremental funding recommended for each country disease component, and its constituent grants, as listed in Table 1 of Attachment 1 to GF/B31/ER26 (“Table 1”);</li> <li>Acknowledges each country disease component’s constituent grants will be implemented by the proposed Principal Recipients listed in Table 1, or any other Principal Recipient(s) deemed appropriate by the Secretariat in accordance with the Global Find policies;</li> <li>Affirms the incremental funding approved under this decision (a) increases the upper-ceiling amount that may be available for the relevant implementation period of each country disease component’s constituent grants, (b) is subject to the availability of funding, and (c) shall be committed in annual tranches; and</li> <li>Delegates to the Secretariat authority to redistribute the overall upper-ceiling of funding available for each country disease component among its constituent grants, provided that the Technical Review Panel (the “TRP”) validates any redistribution that constitutes a material change from the program and funding request initially reviewed and recommended by the TRP.</li> </ol> <p>Table 1: Secretariat’s Funding Recommendation on Additional Funding from the 2014 Allocation. (see attached: Moldova, HIV/AIDS, MDA-H-PAS, MDA-H-PCIMU).</p>

<p>The Board:</p> <ol> <li>Approves additional funding for the next implementation period for the grant listed in Table 2 of Attachment 1 to GF/B31/ER26 (“Table 2”) in the amount indicated, based on the understanding that the amount approved is the upper ceiling rather than the final funding amount for that period and that on-going implementation arrangements for the listed grant shall be pursued by the Secretariat consistent with the principles of the recommendations set forth in the related documentation submitted to the Board and in accordance with Global Fund policies. Approval is also subject to the availability of funding and to the provision that funding for the renewal of such existing grant shall be committed in annual tranches (GF/B25/DP16, paragraph 7 of Annex 1).</li> <li>Reaffirms that the maximum funding amount available for the next implementation period of the grant shall be the sum of the amount set out in Table 2 for the listed grant and the amount of any funds approved for the prior implementation period which have not been utilized during that period, either as undisbursed funds or cash balances held by recipients under the grant.</li> </ol> <p>Table 2: Secretariat’s Funding Recommendation for a Grant Renewal (see attached: Macedonia, MKD-H-MOH)</p>

<p>The Board:</p> <p>Approves extension of the relevant implementation period for the grant listed in Table 3 of Attachment 1 to GF/B31/ER26.</p> <p>Table 3: Secretariat’s Recommendations on Grant Extension (see attached: Burundi, BRN-202-G05-M (BRN-M-SEPCNLS))</p>

<p>The Board:</p> <ol> <li>Approves the incremental funding recommended for each country disease component, and its constituent grants, as listed in Table 1 of Attachment 1 to GF/B31/ER30 ( “Table 1”); provided, however, that the disbursement of any and all funding for the grant “KAZ-T-NCTP” is subject to satisfactory resolution in line with the Global Fund policies by the Republic of Kazakhstan of all recoveries and other OIG matters now pending in draft or final forms;</li> <li>Acknowledges each country disease component’s constituent grants will be implemented by the proposed Principal Recipients listed in Table 1, or any other Principal Recipient(s) deemed appropriate by the Secretariat in accordance with the Global Fund policies;</li> <li>Affirms the incremental funding approved under this decision (a) increases the upper-ceiling amount that may be available for the relevant implementation period of each country disease component’s constituent grants, (b) is subject to the availability of funding, and (c) shall be committed in annual tranches; and</li> <li>Delegates to the Secretariat authority to redistribute the overall upper-ceiling of funding available for each country disease component among its constituent grants, provided that the Technical Review Panel (the “TRP”) validates any redistribution that constitutes a material change from the program and funding request initially reviewed and recommended by the TRP.</li> </ol> <p>GF/B32/EDP26 - Table 1: Secretariat’s Funding Recommendation on Additional Funding from the 2014 Allocation (see Annex for details)</p> <p>Indonesia (IDN-M-PERDHAK and IDN-M-MOH), Kazakhstan (KAZ-T-HOPE and KAZ-T-NCTP), Timor Leste (TLS-M-MOH), Philippines (PHL-M-PSFI), Swaziland (SWZ-M-NERCHA), Zambia (ZMB-C-CHAZ, ZMB-C-MOH, ZMB-M-CHAZ and ZMB-M-MOH)</p>

<p>The Board:</p> <p>Approves extension of the relevant implementation period for the grant listed in Table 2 of Attachment 1 to GF/B31/ER30.</p> <p>Table 2: Secretariat’s Recommendations on Grant Extension (see Annex for details)</p> <p>Tanzania (TNZ-607-G09-T)</p>

Based on the need to accommodate both the Board retreat and meeting, the Board agrees to convene the Thirty-Second Board Meeting in Montreux, Switzerland as an exception to article B.6.1 of the Operating Procedures of the Board and Committees.